A gut bacteria could hold the key to universal blood, revolutionizing transfusion medicine

FHS
May 2, 2024
2:22 am

Study found that exoglycosidases from Akkermansia muciniphila effectively target blood group antigens, potentially converting A and B blood types to ABO-universal blood.

HTA outcomes in the 5EU are growing at 27% with a deep commitment to oncology – Pharmaceutical Technology

Subsequent HTA decisions have determined the advanced therapeutic treatment options available to patients under national health schemes. Credit: ART STOCK CREATIVE via Shutterstock. Health technology

July 13, 2023

Digital Health Funding Surges TO $5.7B in Early 2024

What You Should Know: – The digital health industry is showing signs of strength despite recent economic uncertainties, according to Rock Health’s latest H1 report.

July 9, 2024

Amy Abernethy to step down as Verily’s chief medical officer in latest departure from company

Amy Abernethy, the president of product development and chief medical officer at Verily, a health care spinout of search giant Alphabet, will leave the company

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.